Aditxt, Inc. Files 8-K for Other Events
Ticker: ADTX · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1726711
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
Aditxt filed an 8-K on 4/9/25 for other events and financials.
AI Summary
Aditxt, Inc. filed an 8-K on April 9, 2025, reporting other events and financial statements as of April 8, 2025. The company, formerly known as Aditx Therapeutics, Inc., is incorporated in Delaware and has its principal executive offices in Mountain View, California.
Why It Matters
This filing provides an update on Aditxt, Inc.'s corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, indicating no immediate significant negative or positive events.
Key Players & Entities
- Aditxt, Inc. (company) — Registrant
- Aditx Therapeutics, Inc. (company) — Former company name
- April 8, 2025 (date) — Date of earliest event reported
- April 9, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Mountain View, CA (location) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of April 8, 2025.
When was this 8-K filed with the SEC?
This 8-K was filed on April 9, 2025.
What was Aditxt, Inc. formerly known as?
Aditxt, Inc. was formerly known as Aditx Therapeutics, Inc.
In which state is Aditxt, Inc. incorporated?
Aditxt, Inc. is incorporated in Delaware.
What is the address of Aditxt, Inc.'s principal executive offices?
The address of Aditxt, Inc.'s principal executive offices is 2569 Wyandotte Street, Suite 101, Mountain View, CA 94043.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding Aditxt, Inc. (ADTX).